| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB,ELISA,IHC-P |
| Brand: | Abnova |
| Reference: | PAB4316 |
| Product name: | FNTB polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of FNTB. |
| Gene id: | 2342 |
| Gene name: | FNTB |
| Gene alias: | FPTB|MGC31935 |
| Gene description: | farnesyltransferase, CAAX box, beta |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human FNTB. |
| Protein accession: | PFTB_HUMAN |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1:1000) Western Blot (1:100-500) Immunohistochemistry (1:50-100) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | Formalin-fixed and paraffin-embedded human cancer tissue reacted with FNTB polyclonal antibody (Cat # PAB4316) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining . This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated . BC = breast carcinoma . |
| Applications: | WB,ELISA,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE. Cancer Res. 2001 Dec 15;61(24):8758-68. |